CO4950552A1 - Nueva composicion lectivos de la reabsorcion de seotonina y un bloqueador b - Google Patents
Nueva composicion lectivos de la reabsorcion de seotonina y un bloqueador bInfo
- Publication number
- CO4950552A1 CO4950552A1 CO98039260A CO98039260A CO4950552A1 CO 4950552 A1 CO4950552 A1 CO 4950552A1 CO 98039260 A CO98039260 A CO 98039260A CO 98039260 A CO98039260 A CO 98039260A CO 4950552 A1 CO4950552 A1 CO 4950552A1
- Authority
- CO
- Colombia
- Prior art keywords
- acronym
- designated
- depression
- pharmaceutical composition
- blocker
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una composición farmacéutica que comprende un SSRI-(siglas porlas que se representa a los inhibidores selectivos de la reabsorción de serotonina) en forma de liberación rápida y un ß-bloqueante en forma de liberación sostenida. 1Un método de tratamiento de alcoholismo, ansiedad, depresión, trastorno obsesivo compulsivo (designado por las siglas OCD), trastorno de pánico, dolor crónico, obesidad, demencia senil, migraña, bulimia, anorexia, fobia social, síndrome premenstrual (designado por las siglas PMS), depresión de la adolescencia, tricotilomania, distimia y abuso de sustancias, que comprende administrar una cantidad eficaz o profiláctica de una composición farmacéutica según la reivindicación 1, de acuerdo con una cualquiera de las reivindicaciones 1 a 10, a un afectado con necesidad de ello. 1Una composición farmacéutica según las reivindicaciones 1 a 10 en la producción de un medicamento para el tratamiento o la prevención de alcoholismo, ansiedad, depresión, trastorno obsesivo compulsivo (designado por las siglas OCD), trastorno de pánico, dolor crónico, obesidad, demencia senil, migraña, bulimia, anorexia, fobia social, síndrome premenstrual (designado por las siglas PMS), depresión de la adolescencia, tricotilomanía, distimia y abuso de sustancias.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9714675.7A GB9714675D0 (en) | 1997-07-11 | 1997-07-11 | Novel composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4950552A1 true CO4950552A1 (es) | 2000-09-01 |
Family
ID=10815744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98039260A CO4950552A1 (es) | 1997-07-11 | 1998-07-10 | Nueva composicion lectivos de la reabsorcion de seotonina y un bloqueador b |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0996466A2 (es) |
| JP (1) | JP2002508003A (es) |
| KR (1) | KR20010021644A (es) |
| CN (1) | CN1262627A (es) |
| AP (1) | AP2000001728A0 (es) |
| AR (1) | AR016128A1 (es) |
| AU (1) | AU9340198A (es) |
| BG (1) | BG104119A (es) |
| BR (1) | BR9810996A (es) |
| CA (1) | CA2295822A1 (es) |
| CO (1) | CO4950552A1 (es) |
| DZ (1) | DZ2556A1 (es) |
| EA (1) | EA200000112A1 (es) |
| GB (1) | GB9714675D0 (es) |
| HU (1) | HUP0003074A3 (es) |
| ID (1) | ID24191A (es) |
| IL (1) | IL133869A0 (es) |
| MA (1) | MA24604A1 (es) |
| NO (1) | NO20000107L (es) |
| OA (1) | OA11276A (es) |
| PE (1) | PE99699A1 (es) |
| PL (1) | PL338017A1 (es) |
| SK (1) | SK72000A3 (es) |
| TR (1) | TR200000074T2 (es) |
| WO (1) | WO1999002142A2 (es) |
| ZA (1) | ZA986138B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1121111B1 (en) | 1998-10-15 | 2010-02-10 | Imperial Innovations Limited | Compounds for the treatment of weight loss |
| IL142896A0 (en) | 1998-11-02 | 2002-04-21 | Elan Corp Plc | Multiparticulate modified release composition |
| MXPA02004293A (es) | 1999-10-29 | 2002-10-31 | Euro Celtique Sa | Formulaciones de hidrocodona de liberacion controlada.. |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| GB0004003D0 (en) * | 2000-02-22 | 2000-04-12 | Knoll Ag | Therapeutic agents |
| CN100518827C (zh) | 2000-10-30 | 2009-07-29 | 欧罗赛铁克股份有限公司 | 控释氢可酮制剂 |
| AU2005283829A1 (en) * | 2004-09-17 | 2006-03-23 | Neurocure Ltd | Pindolol for the treating premenstrual syndrome and premenstrual dysphoric disorder |
| CN100469356C (zh) * | 2006-09-08 | 2009-03-18 | 山东益康药业有限公司 | 复方阿替洛尔缓释片及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2732335C2 (de) * | 1976-07-27 | 1983-01-20 | Sandoz-Patent-GmbH, 7850 Lörrach | Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten |
| CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
| EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
| DK0759299T3 (da) * | 1995-08-16 | 2000-08-07 | Lilly Co Eli | Potensering af serotoninrespons |
| EP0792649A1 (en) * | 1996-02-29 | 1997-09-03 | Eli Lilly And Company | Treatment of sleep disorders |
-
1997
- 1997-07-11 GB GBGB9714675.7A patent/GB9714675D0/en active Pending
-
1998
- 1998-07-07 CN CN98806975A patent/CN1262627A/zh active Pending
- 1998-07-07 KR KR1020007000202A patent/KR20010021644A/ko not_active Application Discontinuation
- 1998-07-07 WO PCT/EP1998/004971 patent/WO1999002142A2/en not_active Application Discontinuation
- 1998-07-07 BR BR9810996-0A patent/BR9810996A/pt not_active Application Discontinuation
- 1998-07-07 SK SK7-2000A patent/SK72000A3/sk unknown
- 1998-07-07 AP APAP/P/1999/001728A patent/AP2000001728A0/en unknown
- 1998-07-07 IL IL13386998A patent/IL133869A0/xx unknown
- 1998-07-07 EA EA200000112A patent/EA200000112A1/ru unknown
- 1998-07-07 ID IDW20000035A patent/ID24191A/id unknown
- 1998-07-07 JP JP50818599A patent/JP2002508003A/ja active Pending
- 1998-07-07 AU AU93401/98A patent/AU9340198A/en not_active Abandoned
- 1998-07-07 CA CA002295822A patent/CA2295822A1/en not_active Abandoned
- 1998-07-07 PL PL98338017A patent/PL338017A1/xx unknown
- 1998-07-07 EP EP98946294A patent/EP0996466A2/en not_active Withdrawn
- 1998-07-07 TR TR2000/00074T patent/TR200000074T2/xx unknown
- 1998-07-07 HU HU0003074A patent/HUP0003074A3/hu unknown
- 1998-07-08 DZ DZ980166A patent/DZ2556A1/xx active
- 1998-07-10 MA MA25165A patent/MA24604A1/fr unknown
- 1998-07-10 CO CO98039260A patent/CO4950552A1/es unknown
- 1998-07-10 PE PE1998000612A patent/PE99699A1/es not_active Application Discontinuation
- 1998-07-10 ZA ZA9806138A patent/ZA986138B/xx unknown
- 1998-07-10 AR ARP980103371A patent/AR016128A1/es unknown
-
2000
- 2000-01-10 NO NO20000107A patent/NO20000107L/no not_active Application Discontinuation
- 2000-01-11 OA OA1200000006A patent/OA11276A/en unknown
- 2000-02-01 BG BG104119A patent/BG104119A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20000107D0 (no) | 2000-01-10 |
| AU9340198A (en) | 1999-02-08 |
| ZA986138B (en) | 2000-01-10 |
| ID24191A (id) | 2000-07-13 |
| AR016128A1 (es) | 2001-06-20 |
| EP0996466A2 (en) | 2000-05-03 |
| BG104119A (en) | 2000-12-29 |
| WO1999002142A3 (en) | 1999-04-15 |
| PL338017A1 (en) | 2000-09-25 |
| HUP0003074A2 (hu) | 2001-01-29 |
| KR20010021644A (ko) | 2001-03-15 |
| WO1999002142A2 (en) | 1999-01-21 |
| AP2000001728A0 (en) | 2000-03-31 |
| NO20000107L (no) | 2000-01-10 |
| CN1262627A (zh) | 2000-08-09 |
| OA11276A (en) | 2003-07-31 |
| BR9810996A (pt) | 2000-08-08 |
| TR200000074T2 (tr) | 2000-05-22 |
| MA24604A1 (fr) | 1999-04-01 |
| IL133869A0 (en) | 2001-04-30 |
| PE99699A1 (es) | 1999-12-21 |
| DZ2556A1 (fr) | 2003-02-15 |
| CA2295822A1 (en) | 1999-01-21 |
| JP2002508003A (ja) | 2002-03-12 |
| HUP0003074A3 (en) | 2001-12-28 |
| EA200000112A1 (ru) | 2000-10-30 |
| GB9714675D0 (en) | 1997-09-17 |
| SK72000A3 (en) | 2000-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4950552A1 (es) | Nueva composicion lectivos de la reabsorcion de seotonina y un bloqueador b | |
| BR122012023120B8 (pt) | Composto inibidor da recaptação de serotonina | |
| BR0210616A (pt) | Indóis, benzofuranos e benzotiofenos substituìdos com triamida, composição farmacêutica, uso dos referidos compostos, bem como processo para preparação dos mesmos | |
| DK1023501T3 (da) | Coatet papir omfattende et pseudo-vandmærke og fremgangsmåde til dets fremstilling | |
| DK1238676T3 (da) | Kombination af en serotoningenoptaghæmmer og et atypisk antipsykotikum til anvendelse ved depression, obsessiv-kompulsiv lidelse og psykoser | |
| ATE355272T1 (de) | Inhibierung der raf-kinase durch chinolin-, isochinolin- oder pyridin-harnstoffe | |
| BR9814343A (pt) | Composições e processos para proteção da pele a partir de imunoextição induzida por uv e danos à pele | |
| FR2788438B1 (fr) | Composition pour le traitement de l'obesite et procede de traitement esthetique | |
| ATE377110T1 (de) | Sicherheitsblatt, das eine durchsichtige oder transluzente schicht enthält | |
| BR0308173A (pt) | Processo para a formação de uma camada de amortecimento e processos para a formação de um artigo | |
| ATE250931T1 (de) | Verwendung von 5-ht4 antagonisten zur überwindung der gastrointestinalen beschädigung, die durch inhibitoren der serotonin-wiederaufnahme hervorgerufen werden | |
| ATE367822T1 (de) | Standardisierte extrakte von scutellaria lateriflora | |
| BR0208040A (pt) | Derivados de benzofuran-2-carboxamidas substituìdas | |
| ES2134888T3 (es) | Composicion de musgo de sphagnum y procedimiento de fabricacion de absorbente laminado. | |
| AR043070A1 (es) | Sistema monolitico que contiene una o mas drogas, formado por tres capas con diferentes mecanismos de liberacion | |
| NZ336587A (en) | Spray dried paroxetine compositions using organic solvent selected from pyridine, acetic acid, acetonitrile, acetone, ethanol, propan-1-ol or tetrahydrofuran | |
| ES2144017T3 (es) | Composicion para el tratamiento externo de la piel. | |
| NO20070914L (no) | Fremgangsmater for behandling av nervesystemforstyrrelser og tilstander | |
| SE9303821D0 (sv) | Sätt att åstadkomma hårda element av trä | |
| NO20023150D0 (no) | Fremgangsmåte for fremstilling av citalopram | |
| ATE279415T1 (de) | Antidepressiv wirksame azaheterocyclymethyl- derivative von oxaheterocycyl-anellierten (1,4)- benzodioxanen | |
| ATE357920T1 (de) | Kombinationstherapie mit verwendung eines serotonin-wiederaufnahmehemmers | |
| BR0209342A (pt) | Antidepressivos de azaheterociclilmetila derivados de 2,3 dihidro-1,4-dioxino[2,3-f]quinoxalina; método de tratamento usando tais compostos; processo para prepará-los | |
| DK1635828T3 (da) | 4-(2-phenyloxyphenyl)-piperidin- eller -1,2,3,6-tetrahydropyridinderivater som serotoningenoptagelseshæmmere | |
| DE69922367D1 (de) | Neue arzneimittelkombinationen aus reboxetin und pindolol |